Kate Dellorusso
Stock Analyst at LifeSci Capital
(2.63)
# 2,869
Out of 4,581 analysts
20
Total ratings
57.1%
Success rate
6.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals | Maintained: Hold | $85 | $83.88 | +1.34% | 6 | Jul 11, 2026 | |
| ACRS Aclaris Therapeutics | Initiated Coverage: Buy | $13 | $5.12 | +153.91% | 1 | Jun 1, 2026 | |
| UPB Upstream Bio | Maintained: Buy | $42 | $6.41 | +555.23% | 11 | May 19, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.3065 | - | 2 | May 12, 2026 |
Crinetics Pharmaceuticals
Jul 11, 2026
Maintained: Hold
Price Target: $85
Current: $83.88
Upside: +1.34%
Aclaris Therapeutics
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $5.12
Upside: +153.91%
Upstream Bio
May 19, 2026
Maintained: Buy
Price Target: $42
Current: $6.41
Upside: +555.23%
Mereo BioPharma Group
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3065
Upside: -